Lung cancer and β-glucans: review of potential therapeutic applications

Invest New Drugs. 2017 Aug;35(4):509-517. doi: 10.1007/s10637-017-0449-9. Epub 2017 Mar 16.

Abstract

The potential of natural substances with immunotherapeutic properties has long been studied. β-glucans, a cell wall component of certain bacteria and fungi, potentiate the immune system against microbes and toxic substances. Moreover, β-glucans are known to exhibit direct anticancer effects and can suppress cancer proliferation through immunomodulatory pathways. Mortality of lung cancer has been alarmingly increasingly worldwide; therefore, treatment of lung cancer is an urgent necessity. Numerous researchers are now dedicated to using β-glucans as a therapy for lung cancer. In the present attempt, we have reviewed the studies addressing therapeutic effects of β-glucans in primary and metastatic lung cancer published in the time period of 1991-2016.

Keywords: Drug resistance; Immunomodulatory activity; Lung cancer; β-glucans.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Lung Neoplasms / drug therapy*
  • beta-Glucans / chemistry
  • beta-Glucans / pharmacology
  • beta-Glucans / therapeutic use*

Substances

  • beta-Glucans